Esophageal Cancer and Bisphosphonates
نویسندگان
چکیده
Volume 2 | Issue 1 At the beginning of 2009, Dianne Wysowski of the US Food and Drug Administration summarized 23 reports of esophageal cancer following alendronate use [1]. Wysowski also noted that there had been 31 cases following alendronate use in Europe and Japan and ten cases in which other bisphosphonates had been reported as concomitant or suspect treatment. Median time from exposure to diagnosis had been 2.1 years in the US and 1.3 years in Europe. In the two series, 12 cases with histological information had adenocarcinoma and six had squamous cell carcinoma. Wysowski suggested that oral bisphosphonates should be investigated as a risk factor for esophageal cancer. Introduction
منابع مشابه
Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
OBJECTIVES Concerns have been raised about a possible link between bisphosphonate use, and in particular alendronate, and upper gastrointestinal (UGI) cancer. A number of epidemiological studies have been published with conflicting results. We conducted a systematic review and meta-analysis of observational studies, to determine the risk of esophageal and gastric cancer in users of bisphosphona...
متن کاملOral Bisphosphonates and Risk of Cancer
Bisphosphonates are currently widely used in the treatment and prevention of osteoporosis, as well as in patients with cancer metastases to bone or multiple myeloma. With a 75 million people affected by osteoporosis in the US, Europe and Japan, this represents a significant population being treated with these medications [1]. The benefits conferred by bisphosphonates in terms of reduced mortali...
متن کاملOral bisphosphonates and risk of esophageal cancer: a dose-intensity analysis in a nationwide population.
BACKGROUND Esophageal cancer has been associated with oral bisphosphonate use, but current data are conflicting and devoid of Asian studies where esophageal squamous carcinoma prevails. METHODS We assessed the association between dose intensity, stratified by use duration (observation period) and exposure frequency, of oral bisphosphonates and the risk of esophageal cancer using 16,204 esopha...
متن کاملHypoxia Potentiates the Cytotoxic Effects of Nitrogen-Containing Bisphosphonates in Human Esophageal Cancer Cell Line
متن کامل
ارزیابی ارتباط تغییرات مکانی توزیع سرطان های مری و معده و وضعیت خاک در استان گلستان
Background and purpose: Cancer is the one common cause of death in developed and the developing countries. Still gastrointestinal cancers is a major cause of Deaths from cancerin the north of the IRAN, this part is a place that located on the Esophageal Cancer belt. As well as is one of esophageal cancer focuses in the world. At the north east of IRAN such as TORKAMAN SAHRA that reaches a maxim...
متن کامل